The expression of NKG2D ligands is regulated by c-Myc in AML and AML cell lines rendered resistant to cytarabine express more of the NKG2D ligands ULBP1/2/3 (Nanbakhsh et al., 2014). The gene discussed is KLRK1; the disease is acute myeloid leukemia.